• OPEN AN ACCOUNT
Indian Indices
Sensex
73,895.74 315.20
( 0.43%)
Global Indices
Nasdaq
51,370.81 -161.78
(-0.31%)
Dow Jones
7,725.73 -1.30
(-0.02%)
Hang Seng
66,308.10 794.11
(1.21%)
Nikkei 225
10,680.49 -24.77
(-0.23%)
Forex
USD-INR
95.73 0.08
(0.09%)
EUR-INR
109.20 -0.36
(-0.33%)
GBP-INR
127.12 -0.62
(-0.48%)
JPY-INR
0.61 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.604918
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
41.51
79.76
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

Alpa Laboratories reports consolidated net profit of Rs 1.38 crore in the March 2026 quarter
May 30,2026
Net profit of Alpa Laboratories reported to Rs 1.38 crore in the quarter ended March 2026 as against net loss of Rs 2.12 crore during the previous quarter ended March 2025. Sales declined 21.34% to Rs 31.40 crore in the quarter ended March 2026 as against Rs 39.92 crore during the previous quarter ended March 2025.

For the full year,net profit declined 23.03% to Rs 15.01 crore in the year ended March 2026 as against Rs 19.50 crore during the previous year ended March 2025. Sales declined 5.90% to Rs 105.81 crore in the year ended March 2026 as against Rs 112.45 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales31.4039.92 -21 105.81112.45 -6
OPM %11.460.48 -3.114.22 -
PBDT3.292.66 24 18.7927.87 -33
PBT3.072.08 48 16.7025.67 -35
NP1.38-2.12 LP 15.0119.50 -23